Soluble programmed death-1 is predictive of hepatitis B surface antigen loss in chronic hepatitis B patients after antiviral treatment

BACKGROUND: Hepatitis B surface antigen (HBsAg) loss, a functional cure in patients with chronic hepatitis B (CHB) undergoing antiviral therapy, might be an ideal endpoint of antiviral treatment in clinical practice. The factors that contribute to the functional cure remain unclear, and the predicto...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Ning, Luo, Hao, Kang, Qian, Pan, Jia-Li, Cheng, Ran, Xi, Hong-Li, Chen, Hong-Yu, Han, Yi-Fan, yang, Yu-Ping, Xu, Xiao-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Control Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316942/
https://www.ncbi.nlm.nih.gov/pubmed/34368300
http://dx.doi.org/10.12998/wjcc.v9.i21.5812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316942/
https://www.ncbi.nlm.nih.gov/pubmed/34368300
http://dx.doi.org/10.12998/wjcc.v9.i21.5812

Ejemplares similares